期刊文献+

胃食管反流病治疗进展 被引量:19

Recent progress in treatment of gastroesophageal reflux disease
下载PDF
导出
摘要 胃食管反流病(GERD)一直以来以抑制胃酸分泌尤其是质子泵抑制剂的使用作为主要手段,但部分患者对其反应不佳或存在长期服药引起并发症的风险。目前基于恢复食管下括约肌功能的抗反流治疗得到了广泛重视和积极尝试,创立了手术、经口咽胃底折叠术(TF)、磁性括约肌扩张(MSA)、Stretta、食管下括约肌(LES)电刺激等一批新的治疗方式,可能成为GERD治疗的新方向,但其可行性及安全性评估尚未形成统一意见。 The inhibiting of gastric acid secretion, especially by the dosing of proton pump inhibitor is always the mainstay of treatment for Gastroesophageal reflux disease(GERD), however, some of the patients have poor responses or the risk of causing complications after a long-term dose. Currently, the anti-reflux treatment which is based on the functional restoration of the lower esophageal sphincter has been attended widely and attempted actively. A batch of new treatment modalities such as surgical operation, TF, MSA, Stretta and LES electrical stimulation have been founded, which may be a new therapeutic target for GERD, but their feasibility and safety evaluation have not yet reached a consensus.
出处 《中国内镜杂志》 北大核心 2015年第10期1090-1094,共5页 China Journal of Endoscopy
基金 国家自然科学基金(No:81173392)
关键词 胃食管反流病 食管下括约肌 治疗 gastroesophageal reflux disease lower esophageal sphincter treatment
  • 相关文献

参考文献4

二级参考文献75

  • 1Savarino E;Pohl D;Zentilin P.Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease,2009(09).
  • 2Kahrilas PJ;Dodds WJ;Hogan WJ.Esophageal peristaltic dysfunction in peptic esophagitis,1986(47).
  • 3Spechler SJ,Castell DO.Classification of oesophageal motility abnormalities. Gut . 2001
  • 4Mark Fox,Carole Barr,Suzanne Nolan,Miranda Lomer,Angela Anggiansah,Terry Wong.The Effects of Dietary Fat and Calorie Density on Esophageal Acid Exposure and Reflux Symptoms[J]. Clinical Gastroenterology and Hepatology . 2007 (4)
  • 5John E. Pandolfino,Hashem B. El–Serag,Qing Zhang,Nimeesh Shah,Sudip K. Ghosh,Peter J. Kahrilas.Obesity: A Challenge to Esophagogastric Junction Integrity[J]. Gastroenterology . 2006 (3)
  • 6Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut 2011; 60:869-876 [PMID: 21303915 DOI: 10.1136/ gut.2010.212423].
  • 7Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010; 22:e256-e261 [PMID: 20465592 DOI: 10.1111/j.1365-2982.2010.01511.x].
  • 8Gennaro N, Portale G, Gallo C, Rocchietto S, Caruso V, Costantini M, Salvador R, Ruol A, Zaninotto G. Esophageal achalasia in the Veneto region; epidemiology and treatment. Epidemiology and treatment of achalasia. J Gastrointest Surg 2011; 15:423-428 [PMID: 21116729 DOE 10.1007/ s11605-010-1392-7].
  • 9Marlais M, Fishman JR, Fell JM, Haddad MJ, Rawat DJ. UK incidence of achalasia: an 11-year national epidemiological study. Arch Dis Child 2011; 96:192-194 [PMID: 20515971 DOE !0.1136/ adc.2009.171975].
  • 10Enestvedt BK, Williams JL, Sonnenberg A. Epidemiology and practice patterns of achalasia in a large multi-centre database. Aliment Pharmacol Ther 2011; 33:1209-1214 [PMID: 21480936 DOI: 10.1111/j.1365-2036.2011.04655.x].

共引文献60

同被引文献151

引证文献19

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部